The updated 2023 EULAR recommendations for treatment of systemic sclerosis bring notable changes to recommendations for skin, peripheral vascular disease, interstitial lung disease and pulmonary arterial hypertension therapies, based on newer evidence. These updates provide the first glimmer of personalized pa...
In an interview withOncLive®, during a State of the Science™ on Breast Cancer, Bagegni, an assistant professor of Medicine at the Washington University School of Medicine, detailed ongoing research and possibilities for the treatment landscape in the future, which includes investigating ...
“These encouraging, early data showed that treatment with BI 1015550 slowed the rate of lung function decline in patients who were not on approved antifibrotics, as well as those who were taking existing antifibrotic therapy,” commented Luca Richeldi, Professor of Respiratory Medicine at the Univ...
Branden Carlson still getting the walk on treatment at every made three, the crowd loves it. Although, this crowd is into EVERYTHING tonight. –8:54 PM Eddie Sefko @ESefko Some college kid named Jake just hit the half-court shot at the OKC-Dallas game and pocketed $20,000. He t...
The use of ultrasound as a tool in the clinical management of patients with rheumatoid arthritis (RA) is gaining in attention. Haavardsholm and colleagues[1]presented results from the randomized, controlled ARCTIC trial (NCT01205854), which examined whether treatment strategies based on ultrasound as...
Promising treatment for gastrointestinal stromal tumors About 1,200 Germans are diagnosed with gastrointestinal stromal tumors every year—a rare type of cancer in which the tumors develop in the walls of the digestive organs and quickly develop resistance to common precision ... ...
Long-term treatment with c alcium channel blockers, bosentan, sildenafil citrate, and/or oxygen lowered PAP , improved symptoms, and prevented the recurrence ofHAPE. Conclusion: Children l iving at altitude who develop HAPE should undergo screening for diagnosis of und erlying cardiopulmonary ...
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of diseases in three main therapy areas – Oncology, Cardiovascular & Metabolic Diseases...